Glox Therapeutics

Glox Therapeutics Awarded Share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate

£500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosis Programme delivered by CF AMR Syndicate offers cross-sector collaboration and support to address urgent unmet need. 21 January 2025 -- Glasgow, UK -- Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based...

Glox Therapeutics Awarded Share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate

£500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosis Programme delivered by CF AMR Syndicate offers cross-sector collaboration and support to address urgent unmet need 21 January 2025, Glasgow, UK – Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on...
11 The Square University Of Glasgow University Avenue Glasgow G12 8QQ